Abiopharma

Bausch Health Notification

Bausch Health Provides Update on RED-C Phase 3 Clinical Trials

AMN Healthcare to Hold Fourth Quarter and Full Year 2025 Earnings Conference Call on Thursday, February 19, 2026

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Canopy Growth Communication - Canopy Growth to Report Third Quarter Fiscal 2026 Financial Results on February 6, 2026

Affera™ momentum continues as Medtronic announces CE Mark in Europe and U.S. IDE first cases for Sphere-360™ PFA catheter to treat paroxysmal atrial fibrillation

New Form 424B5 - Axogen, Inc. Filed: 2026-01-23 AccNo: 0000805928-26-000025 Size: 1 MB

New Form PRE 14A - AGILENT TECHNOLOGIES, INC. Filed: 2026-01-23 AccNo: 0001193125-26-020129 Size: 22 MB

NextCure Provides Business Update

FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain

Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium

New Form 424B3 - DAXOR CORP Filed: 2026-01-23 AccNo: 0001493152-26-003309 Size: 870 KB

New Form EFFECT - ClearPoint Neuro, Inc. Filed: 2026-01-22 AccNo: 9999999995-26-000264 Size: 2 KB

New Form DEFA14A - EXACT SCIENCES CORP Filed: 2026-01-23 AccNo: 0001193125-26-020096 Size: 20 KB

New Form 424B5 - Corvus Pharmaceuticals, Inc. Filed: 2026-01-23 AccNo: 0001104659-26-005967 Size: 1 MB